EMN
66
-6
HP
40
3
VIX
25
-8
GM
63
-3
SNA
53
-2
AEP
56
-3
WHR
53
-6
TRV
42
-3
IP
65
-2
MA
67
-2
SLB
60
3
HD
46
-4
O
37
-5
FCX
47
-2
SHW
56
-5
AFL
62
-2
AIG
51
-3
DNB
34
-4
MDT
41
-3
KEY
43
-3
EMN
66
-6
HP
40
3
VIX
25
-8
GM
63
-3
SNA
53
-2
AEP
56
-3
WHR
53
-6
TRV
42
-3
IP
65
-2
MA
67
-2
SLB
60
3
HD
46
-4
O
37
-5
FCX
47
-2
SHW
56
-5
AFL
62
-2
AIG
51
-3
DNB
34
-4
MDT
41
-3
KEY
43
-3
Financhill
Back

Reading International Vs. Keros Therapeutics Industry Stock Comparison

Sell
37

RDIB
Reading International

Last Price:
13.29
Seasonality Move:
8.13%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.47
Seasonality Move:
4.22%
Sell
37
Reading International (RDIB) is a Sell

Is Reading International a Buy, Sell or Hold?

  • The current Reading International [RDIB] share price is $13.05. The Score for RDIB is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RDIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RDIB Stock Price Chart

What is Reading International's stock price today?

  • The Reading International share price today is $13.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RDIB is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

RDIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.47 Sell
Relative Strength Index (14 RSI): 45.31 Sell
Chaikin Money Flow: -2060 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.7 - 14.68) Sell
Bollinger Bands (100): (13.78 - 15.82) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

RDIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.11 Sell
20-day SMA: 13.41 Sell
50-day SMA: 14.6 Sell
200-day SMA: 14.51 Sell
8-day EMA: 13.13 Sell
20-day EMA: 13.49 Sell
50-day EMA: 14.16 Sell
200-day EMA: 15.3 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

Reading International Earnings Growth & RDIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Reading International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):